TIAA CREF Investment Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-650,350
| Closed | -$228 | – | 3162 |
|
|
2016
Q3 | $228 | Hold |
650,350
| – | – | ﹤0.01% | 3036 |
|
|
2016
Q2 | $303K | Buy |
650,350
+111,742
| +21% | +$52.1K | ﹤0.01% | 3030 |
|
|
2016
Q1 | $733K | Hold |
538,608
| – | – | ﹤0.01% | 2631 |
|
|
2015
Q4 | $792K | Hold |
538,608
| – | – | ﹤0.01% | 2715 |
|
|
2015
Q3 | $851K | Buy |
538,608
+13,334
| +3% | +$21.1K | ﹤0.01% | 2663 |
|
|
2015
Q2 | $893K | Buy |
525,274
+83,972
| +19% | +$143K | ﹤0.01% | 2746 |
|
|
2015
Q1 | $613K | Buy |
441,302
+21,473
| +5% | +$29.8K | ﹤0.01% | 2857 |
|
|
2014
Q4 | $634K | Sell |
419,829
-27,303
| -6% | -$41.2K | ﹤0.01% | 2883 |
|
|
2014
Q3 | $921K | Sell |
447,132
-21,451
| -5% | -$44.2K | ﹤0.01% | 2676 |
|
|
2014
Q2 | $1.43M | Sell |
468,583
-376,221
| -45% | -$1.15M | ﹤0.01% | 2499 |
|
|
2014
Q1 | $2.11M | Buy |
844,804
+231,456
| +38% | +$579K | ﹤0.01% | 2207 |
|
|
2013
Q4 | $3.04M | Buy |
613,348
+312,335
| +104% | +$1.55M | ﹤0.01% | 1983 |
|
|
2013
Q3 | $683K | Sell |
301,013
-22,191
| -7% | -$50.4K | ﹤0.01% | 2840 |
|
|
2013
Q2 | $718K | Buy |
+323,204
| New | +$718K | ﹤0.01% | 2788 |
|
TIAA CREF Investment Management's RXII Position: Q4 2016 in Review
TIAA CREF Investment Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 650,350 shares — an estimated $228 sold.
TIAA CREF Investment Management first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $3.04M in Q4 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- TIAA CREF Investment Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- TIAA CREF Investment Management sold 650,350 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $228.
- TIAA CREF Investment Management first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
- TIAA CREF Investment Management's GALENA BIOPHARMA INC COM position peaked at $3.04M in Q4 2013.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on TIAA CREF Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.